Navigation Links
Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of MST-188
Date:1/8/2014

tee that expansion will not compromise the ability to enroll a sufficiently homogenous patient population and conduct a successful study. Given that most of the study investigators will be pediatric hematologists, the Company expects the majority of enrolled subjects will be children and young adults.

About Mast Therapeutics
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California.  The Company is leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from over two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers, to develop MST-188, its lead product candidate, for serious or life-threatening diseases with significant unmet needs.  MST-188 is a cytoprotective, hemorheologic, anti-inflammatory and anti-thrombotic agent that has potential utility in diseases or conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow). 

The Company is enrolling subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease.  In early 2014, the Company plans to initiate a phase 2, clinical proof of concept study in acute limb ischemia that will evaluate whether MST-188 improves the effectiveness of existing thrombolytic agents.  The Company also is evaluating development options in heart failure.  More information can be found on the Company's web site at www.masttherapeutics.com.  (Twitter: @MastThera)

Mast Therapeutics™ and the corporate logo are trademarks of Mast Therapeutics, Inc.

Forward Looking Statements
Mast Therapeutics cautions you that statements included in this press release that are not a description of h
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
2. Agile Therapeutics Appoints Dr. Elizabeth Ijeoma Onyemelukwe Garner as Chief Medical Officer
3. Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
4. Advinus Therapeutics, a TATA Enterprise, Meets Year 1 Milestone in Drug Discovery Alliance
5. Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients
6. Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics
7. Shield Therapeutics ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
8. PTC Therapeutics To Present At The J.P. Morgan Healthcare Conference
9. Mast Therapeutics Announces Positive Data In Model Of Heart Failure
10. Moderna Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference
11. Aratana Therapeutics Acquires Okapi Sciences NV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)...  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today ... the company as Vice President, Medical Affairs. ... Bill Aurora to the Neurocrine team as our ... President and Chief Executive Officer of Neurocrine Biosciences. "Bill,s ... coupled with his extensive network and influence with psychiatric ...
(Date:5/4/2015)... 4, 2015 Microbrush International, a leading developer, ... dental restorative procedures, today announced the acquisition of ... innovative sectional matrix system used in dental restorative ... the opportunity to add DentiSmart to our growing ... , VP and General Manager of Microbrush. "DentiSmart,s ...
(Date:5/4/2015)... , May 4, 2015  The board of directors of ... a dividend for the second quarter of 2015 of $0.50 ... dividend is payable June 10, 2015, to shareholders of record ... About Eli Lilly and Company Lilly is a global healthcare ... for people around the world. We were founded more than ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... Inc.,announced today that a new analysis of pivotal ... Institute at Harbor-UCLA Medical Center,showed that initial treatment ... CIII had similar effects on subjects, regardless of,weight ... were presented today,at the 2008 Endocrine Society Annual ...
... 17 Champions,Biotechnology, Inc. (OTC Bulletin Board: CSBR), ... platforms and tumor specific data to,enhance the value ... begun,preclinical development of the lead Benzoylphenylurea (BPU) sulfur ... compound has shown,promising activity against in vitro and ...
Cached Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate 2Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate 3
(Date:5/4/2015)... R.I. (PRWEB) May 04, 2015 Johnson & ... $40 million engineering and science academic center on Wednesday, April ... the ground for land made available by the re-alignment of ... the corner of Friendship and Chestnut streets in Providence, is ... built on a parcel of land the university purchased in ...
(Date:5/4/2015)... The opportunity for children to dream of a bright ... behind The Fairy Godmother Next Door, a new children’s picture ... , The inspiration for the enchanting story of a fairy ... desire to be a fairy godmother. , “My wish came ... neighbors’ children since they were born. We discuss fairies and ...
(Date:5/4/2015)... Calif. (PRWEB) May 04, 2015 Now ... recognizes IPC clinical leaders who have made outstanding contributions ... patients they serve, both in acute and post-acute care ... the Year, Post-Acute Provider of the Year, Advanced Practice ... and Specialist Provider of the Year. Recipients are selected ...
(Date:5/4/2015)... Ticket Down is a reputable source for ... Arena in Charlottesville, VA. McCartney is one of ... business and this beloved performer continues to roll along with ... of two legendary groups: Wings and The Beatles, has been ... 2013 on the “Out There” tour and has continually added ...
(Date:5/4/2015)... CA (PRWEB) May 04, 2015 ... ribbon cutting ceremony at their brand new, 13,700 square ... year. The new building will not only provide fertility ... but will also offer community and educational events to ... new facility is located next door to their current ...
Breaking Medicine News(10 mins):Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... epilepsy and low socioeconomic status (SES) are more likely ... lower overall quality of life. The study also indicates ... more often and had more visits to a general ... findings are now available in Epilepsia , a ...
... a helpless and heartbreaking situation for families as they try ... they may not know is that there,s a society on ... this dangerous and possibly fatal behavior. University of ... social support group as social networks grow on the Web. ...
... Women & Infants Hospital of Rhode Island has been ... the Clinical Sciences Institute of OptumHealth, an independent audit ... providers are created equal. For complex medical conditions, ... evaluation process, OptumHealth developed Centers of Excellence networks that ...
... Polygamy practiced by some 19th century Mormon men had the ... women in plural marriages, say scientists from Indiana University Bloomington ... Evolution and Human Behavior . Simply put, the ... was likely to produce. "Although it,s great in terms ...
... patients, according to a study published in the Annals ... rates that are 34 percent lower, while spending nearly 22 ... high quality can coexist with lower cost. ... comes at a time when the affordability of health care ...
... , MONDAY, Feb. 21 (HealthDay News) -- The experience ... emotional lives of women than men, a new study suggests. ... need additional care, including follow-up and possibly counseling to optimally ... Holterhues of the department of dermatology at Erasmus MC ...
Cached Medicine News:Health News:Health care disparities seen in epilepsy patients with low socioeconomic status 2Health News:Research uncovers a secret society connecting through the Internet 2Health News:Women & Infants named Center of Excellence for Neonatal Care for fifth year 2Health News:Polygamy hurt 19th century Mormon wives' evolutionary fitness 2Health News:Polygamy hurt 19th century Mormon wives' evolutionary fitness 3Health News:High-quality care associated with lower cost in trauma 2Health News:Surviving Melanoma May Take Different Toll on Women, Men 2Health News:Surviving Melanoma May Take Different Toll on Women, Men 3
... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. This ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
... bottle becomes preservative-free on eye contactits ... and water on eye contact. It ... to moderate dryness or eyes that ... you can have the benefits of ...
... Contact Lens Comfort Drops improve comfort on contact ... contact lenses from your disinfecting system or from ... your finger and place one or two drops ... it in your eyethe lens will go in ...
Medicine Products: